Drug profile

The FDA adverse-event record for Firocoxib 0.82% Oral Paste

67 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Firocoxib 0.82% Oral Paste. See the species affected, top reactions, and outcomes below.

67
adverse-event reports
3.0%
death-coded share
Unknown
most-reported species
27
Uncoded sign - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
67
Total Reports
2
Deaths Reported
3.0%
Death Rate

Active Ingredients

Firocoxib 0.82% Oral Paste

Administration Routes

UnknownOralOphthalmic

Species Affected

Unknown 35
Horse 31
Human 1

Most Affected Breeds

Unknown 37
Horse (unknown) 9
Quarter Horse 8
Thoroughbred 4
Appaloosa 1
Arab 1
Morgan 1
Tennessee Walking Horse 1
Miniature 1
Saddlebred - American 1

Most Reported Reactions

Uncoded sign 27
Containers, Abnormal 11
Product Defect, General 8
Other abnormal test result NOS 7
Odor, Abnormal 7
Locking Mechanism Abnormal 5
Diarrhoea 3
Tubes, Leaking 3
Containers, Damaged 2
Loose stool 2
Death 2
Musculoskeletal disorder NOS 2

Outcome Breakdown

Outcome Unknown
21 (65.6%)
Ongoing
5 (15.6%)
Recovered/Normal
4 (12.5%)
Died
2 (6.3%)

Firocoxib 0.82% Oral Paste Adverse Event Insights

67 reports name Firocoxib 0.82% Oral Paste; 2 recorded a death outcome (3.0% of reported events, not a population-level mortality rate). Active ingredient: Firocoxib 0.82% Oral Paste. Administration routes: Unknown, Oral, Ophthalmic.

By species: Unknown (35 reports), Horse (31 reports), Human (1 reports). By breed: Unknown (37), Horse (unknown) (9), Quarter Horse (8).

Leading clinical signs: Uncoded sign (27), Containers, Abnormal (11), Product Defect, General (8), Other abnormal test result NOS (7). Outcome, 32 coded reports: Outcome Unknown leads at 65.6%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.